Rise of the Machines – Technology and “patient-driven” innovation in the treatment #T1DRoM
The real cost of Time in Range – what it takes to replace Hba1C #ATTD2018
As #DIYPancreas systems become more prevalent, how can healthcare professionals support users?
#SpareARose and #Insulin4All – Highlighting the global healthcare dilemma
Designing by numbers. Can #WeAreNotWaiting influence commercial APS systems?
Enough is enough. I can’t go on…. Details of the EMA Submission Fiasp CSII study
Fiasp – going off-label. Attempting to handle the unwanted side effects and retain the rapid effectiveness